RVMD

NASDAQ · Biotechnology

Revolution Medicines Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$192.76

+1.81 (+0.95%)

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 26 93%

Hold 2 7%

Sell 0 0%

Price Target

Analyst Price Target -40.8% upside

Low Target $80.83

Average Target $114.11

High Target $120.13

Current Price $192.76

Current
$192.76

Target
$114.11

$80.83 $114.11 avg $120.13

Scenario Analysis

Bear Case

$80.83

-58.1%

Low target

Base Case

$114.11

-40.8%

Avg target

Bull Case

$120.13

+-37.7%

High target

Risk/Reward

0.6x

Unfavorable

Price in Context

52-Week High

$224.31

-14.1% from high

52-Week Low

$42.18

+357.0% from low

50-Day SMA

$94.85

+103.2% vs SMA

200-Day SMA

$58.23

+231.0% vs SMA

RSI (14)

62.5

Neutral

Target vs 52W High

$114.11

-49.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.6%
AMGN Amgen Inc	Hold	43	47%	$190.87	-51.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+140.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.2%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-13.6%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%